American Well
AMWL
Market cap $112M

6.78 USD

-0.38

5.31%

At close Jun 13, 4:00 PM EDT

After hours

6.78

+0.00

0.00%

1 day

-5.31%

5 days

-4.10%

1 month

-10.79%

3 months

-14.07%

6 months

-27.10%

Year to date

-3.69%

1 year

-13.63%

5 years

-98.53%

10 years

-98.53%

About: American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

Employees: 877

Healthcare Health Information Services

0

Funds holding %

of 7,296 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

5,200% more call options, than puts

Call options by funds: $530K | Put options by funds: $10K

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

0% less capital invested

Capital invested by funds: $48.4M [Q4 2024] → $48.1M (-$241K) [Q1 2025]

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

5% less funds holding

Funds holding: 65 [Q4 2024] → 62 (-3) [Q1 2025]

5.05% less ownership

Funds ownership: 48.79% [Q4 2024] → 43.74% (-5.05%) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$7.50

11%

upside

Avg. target

$8.13

20%

upside

High target

$9

33%

upside

4 analyst ratings

0 positive

0%

4 neutral

100%

0 negative

0%

Piper Sandler Jessica Tassan	18%upside $8	Neutral Reiterated	23 May 2025
UBS Kevin Caliendo	33%upside $9	Neutral Maintained	8 May 2025
Stifel David Grossman	18%upside $8	Hold Maintained	2 May 2025
Truist Securities Jailendra Singh	11%upside $7.50	Hold Maintained	10 Apr 2025

See Analyst Rankings

Financial journalist opinion

Zacks Investment Research

Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?

HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.

Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?

Amwell makes grant to new employee under inducement plan

BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell.

Amwell makes grant to new employee under inducement plan

Zacks Investment Research

All You Need to Know About American Well (AMWL) Rating Upgrade to Buy

American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About American Well (AMWL) Rating Upgrade to Buy

Zacks Investment Research

Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect?

The consensus price target hints at a 46.5% upside potential for American Well (AMWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect?

Zacks Investment Research

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Here is how American Well Corporation (AMWL) and Claritev Corporation (CTEV) have performed compared to their sector so far this year.

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for American Well (AMWL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript

American Well Corporation (NYSE:AMWL ) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Charles Rhyee - TD Cowen Jailendra Singh - Truist Stan Berenshteyn - Wells Fargo Securities LLC Eric Percher - Nephron David Larsen - BTIG Matt Shea - Needham Operator Good day, and thank you for standing by. Welcome to Amwell's First Quarter 2025 Earnings Conference Call.

American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript

Zacks Investment Research

American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates

American Well Corporation (AMWL) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to loss of $5 per share a year ago.

American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates

Amwell® Announces Results for First Quarter 2025

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report.

Amwell® Announces Results for First Quarter 2025

Amwell® to participate in upcoming investor conferences

BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences: On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.

Amwell® to participate in upcoming investor conferences

See News Rankings

Charts implemented using Lightweight Charts™